ArticleMediators of inflammation2026
Low PTGDS Expression Facilitates HNSCC by Suppressing Programmed Cell Death and Reducing B Cell-Mediated Immune Responses.
Article in Mediators of inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Low PTGDS Expression Facilitates HNSCC by Suppressing Programmed Cell Death and Reducing B Cell-Mediated Immune Responses.Mediators of inflammation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Head and neck squamous cell carcinoma (HNSCC) constitutes a significant global disease burden. Evasion of programmed cell death (PCD) is a hallmark of HNSCC progression. Cancer-associated fibroblasts (CAFs) are a major cellular component of the HNSCC tumor microenvironment (TME). However, the mechanism by which CAFs contribute to PCD resistance remains poorly understood. This study included 24 single-cell sequencing samples, the Cancer Genome Atlas (TCGA) data, and spatial transcriptome data from HNSCC samples. Single-cell data were clustered using the Seurat package, and pseudotemporal trajectory analysis of CAF subsets was performed with Monocle2. The random forest algorithm was used to assess the prognostic importance of candidate genes. The ssGSEA and CIBERSORT algorithms were used to assess immune cell infiltration patterns in the TCGA samples. Gain-of-function assays, Western blotting, and immunohistochemistry were conducted to validate the biological functions of key targets. Here, we identified seven CAF subsets and clarified their potential differentiation directions. Thirty-two CAF-associated PCD regulators with prognostic significance were identified, among which, prostaglandin D2 synthase (PTGDS) and squalene epoxidase (SQLE) are the most important genes. PTGDS is significantly downregulated in HNSCC and associated with favorable prognosis. PTGDS overexpression significantly inhibited clonogenicity, proliferation, and invasion while promoting apoptosis in HNSCC cells (p < 0.05). In addition, PTGDS expression is significantly enriched in B cell-related pathways. Mechanistically, PTGDS overexpression increased chemokine (C-X-C motif) ligand 13 (CXCL13) expression and enhanced immune cell infiltration. These findings identified PTGDS as a central regulator linking CAF-mediated PCD resistance and B cell immune modulation in HNSCC, suggesting its potential as both a diagnostic biomarker and therapeutic target.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.